Zura Bio Limited
Zura Bio Limited (ZURA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ZURA · as of Jun 8, 2026
Key Statistics
Explore Zura Bio Limited Data
zura stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The ZURA analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +324.93% upside from the current price of $3.53.
Competitors & Peers
zura competitorsZURA
AARD
ARCT
ASMB
ENTA
FHTXStock Performance
Full HistoryAbout Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its ke…
what is zura bio limited · zura stock overview · zura bio limited company profile · who is zura bio limited ceo · zura NASDAQ · zura bio limited headquarters · zura bio limited business segments
About Stock Overview & Key Data
Zura Bio Limited (ZURA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 21, 2023. As of the latest trading session, ZURA stock price is $3.53, with a market capitalization of $229.5M. The stock has returned +182.40% over the past 12 months and -32.63% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Zura Bio Limited stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Zura Bio Limited reported revenue of — and net income of -$68.7M. For detailed data — including Zura Bio Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Zura Bio Limited (ZURA) stock price is $3.53. The stock is traded on NASDAQ under the ticker symbol ZURA. The 52-week range is $1.00 – $7.44.